U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Pancrazio S.P.A. - 04/04/2016
  1. Warning Letters


Pancrazio S.P.A.

Pancrazio S.P.A.

United States

Issuing Office:

United States


Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
 Food and Drug Administration
Washington, DC

April 4, 2016

Mr. Antonio Pancrazio, President/Director
Pancrazio S.P.A.
Via Angeloni, No 1 - Zona Industriale
Cava Dei Tirreni,

Dear Mr. Pancrazio:

The Food and Drug Administration (FDA) has completed an evaluation of your firm's corrective actions in response to our Warning Letter #427974, issued April 18, 2014. Based on our evaluation, it appears you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.



Robyn R. Jones
Compliance Officer
Office of Compliance
Center for Food Safety
    and Applied Nutrition  

Back to Top